Fareed Kureshy, president and CEO of AutoGenomics, said: “This patent is the result of our collaboration with Dr Erik Thunnissen, a prominent clinician and opinion leader in the field of human papillomavirus (HPV).
“with increasing demands for alternative technologies to meet the evolving need for genotyping we are excited that we can offer an automated solution that can significantly enhance workflow efficiency in the laboratory.”